The NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.
A Royal Manchester Children’s Hospital patient is the first young person in the world to participate in a study researching a new drug to treat itching caused by kidney failure.
Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Pioneering care and research across Manchester University Hospitals NHS Foundation Trust (MFT) features in a new national exhibition on cancer breakthroughs.
The country’s largest clinical study investigating the best gap between first and second COVID-19 vaccine doses for pregnant women has launched in Greater Manchester.
The exceptional contribution of three MFT colleagues to research and innovation has been recognised by the Manchester Academic Health Science Centre (MAHSC).
For nine-year-old Leo, and his mum, Lisa, taking part in a clinical trial at the NIHR Manchester Clinical Research Facility has been important for many reasons.